25 Feb 2022 - {{hitsCtrl.values.hits}}
Early research suggesting that a popular non-psychoactive compound derived from marijuana might help prevent or treat COVID-19 warrants further investigation in rigorous clinical trials, researchers say. Several recent laboratory studies of cannabidiol, or CBD, have shown promising results. Marsha Rosner of the University of Chicago led a team that found CBD appeared to help curb SARS-CoV-2 in infected cells in laboratory experiments. Using small doses of highly purified CBD that approximate what patients receive in an oral drug already approved for severe epilepsy, Rosner and colleagues found that CBD did not keep the coronavirus from infecting cells in test tubes. However the findings don’t say that this would work on patients; rather it makes a strong case for clinical trials. Source : Reuters
20 Dec 2024 6 hours ago
20 Dec 2024 7 hours ago
20 Dec 2024 8 hours ago
20 Dec 2024 9 hours ago
20 Dec 2024 9 hours ago